MCRB - Seres Therapeutics GAAP EPS of -$2.31 misses by $0.15 revenue of $7.13M misses by $6.62M
2023-03-07 07:01:08 ET
- Seres Therapeutics press release ( NASDAQ: MCRB ): FY GAAP EPS of -$2.31 misses by $0.15 .
- Revenue of $7.13M (-95.1% Y/Y) misses by $6.62M .
For further details see:
Seres Therapeutics GAAP EPS of -$2.31 misses by $0.15, revenue of $7.13M misses by $6.62M